Tuberculosis: Epidemiology and control

Mediterranean Journal of Hematology and Infectious Diseases

Volumn 6, Issue 1, 2014, Pages

  Sulis, Giorgia ^a   Roggi, Alberto ^a   Matteelli, Alberto ^b   Raviglione, Mario C ^b  

^a UNIVERSITY OF BRESCIA   (Italy)

^b WORLD HEALTH ORGANIZATION   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; CAPREOMYCIN; KANAMYCIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT; TUBERCULOSTATIC AGENT;

BACTERIAL CLEARANCE; BACTERIAL STRAIN; BACTERIAL TRANSMISSION; CONTROL STRATEGY; EPIDEMIC; GEOGRAPHIC DISTRIBUTION; HEALTH PROMOTION; HIGH RISK POPULATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INCIDENCE; INFECTION RATE; INFECTION RISK; MIXED INFECTION; MORTALITY; MULTIDRUG RESISTANCE; MULTIDRUG RESISTANT TUBERCULOSIS; MYCOBACTERIUM TUBERCULOSIS; PATIENT MONITORING; POPULATION MIGRATION; PREVALENCE; PRISONER; REVIEW; RISK ASSESSMENT; TREATMENT DURATION; TUBERCULOSIS; TUBERCULOSIS CONTROL; VULNERABLE POPULATION;

EID: 84926284959     PISSN: None     EISSN: 20353006     Source Type: Journal    
DOI: 10.4084/mjhid.2014.070     Document Type: Review

References (50)

1. World Health Organization (WHO). Global Tuberculosis Report 2013. Geneva, 2013. Available at: http://www.who.int/iris/bitstream/10665/91355/1/9789241564656_eng.pdf?ua=1.
2. World Health Organization (WHO). Treatment of tuberculosis guidelines, 4th ed. Geneva, 2010 (WHO/HTM/STB/2009.420). Available at: http://whqlibdoc.who.int/publications/2010/9789241547833_eng.pdf?ua=1.
3. Floyd S, Sismanidis C, Yamada N, Daniel R, Lagahid J, Mecatti F, Vianzon R, Bloss E, Tiemersma E, Onozaki I, Glaziou P, Floyd K. Analysis of tuberculosis prevalence surveys: new guidance on best-practice methods. Emerg Themes Epidemiol. 2013 Sep 28;10(1):10. http://dx.doi.org/10.1186/1742-7622-10-10
4. Nadjane Batista Lacerda S, Cristina de Abreu Temoteo R, Maria Ribeiro Monteiro de Figueiredo T, Darliane Tavares de Luna F, Alves Nunes de Sousa M, Carlos de Abreu L, Luiz Affonso Fonseca F. Individual and social vulnerabilities upon acquiring tuberculosis: a literature systematic review. Int Arch Med. 2014 Jul 12;7:35. http://dx.doi.org/10.1186/1755-7682-7-35
5. Abarca Tomás B, Pell C, Bueno Cavanillas A, Guillén Solvas J, Pool R, Roura M. Tuberculosis in migrant populations. A systematic review of the qualitative literature. PLoS One. 2013 Dec 5;8(12):e82440. http://dx.doi.org/10.1371/journal.pone.0082440
6. álvarez JL, Kunst AE, Leinsalu M, Bopp M, Strand BH, Menvielle G, Lundberg O, Martikainen P, Deboosere P, Kalediene R, Artnik B, Mackenbach JP, Richardus JH. Educational inequalities in tuberculosis mortality in sixteen European populations. Int J Tuberc Lung Dis. 2011 Nov;15(11):1461-7, i. http://dx.doi.org/10.5588/ijtld.10.0252
7. Lönnroth K, Castro KG, Chakaya JM, Chauhan LS, Floyd K, Glaziou P, Raviglione MC. Tuberculosis control and elimination 2010-50: cure, care, and social development. Lancet. 2010 May 22;375(9728):1814-29. http://dx.doi.org/10.1016/S0140-6736(10)60483-7
8. Rehm J, Samokhvalov AV, Neuman MG, Room R, Parry C, Lönnroth K, Patra J, Poznyak V, Popova S. The association between alcohol use, alcohol use disorders and tuberculosis (TB). A systematic review. BMC Public Health. 2009 Dec 5;9:450. http://dx.doi.org/10.1186/1471-2458-9-450
9. Muniyandi M, Ramachandran R. Socioeconomic inequalities of tuberculosis in India. Expert Opin Pharmacother. 2008 Jul;9(10):1623-8. http://dx.doi.org/10.1517/14656566.9.10.1623
10. Hwang LY, Grimes CZ, Beasley RP, Graviss EA. Latent tuberculosis infections in hard-to-reach drug using population-detection, prevention and control. Tuberculosis (Edinb). 2009 Dec;89 Suppl 1:S41-5. http://dx.doi.org/10.1016/S1472-9792(09)70010-1
11. van Hest NA, Aldridge RW, de Vries G, Sandgren A, Hauer B, Hayward A, Arrazola de O-ate W, Haas W, Codecasa LR, Caylà JA, Story A, Antoine D, Gori A, Quabeck L, Jonsson J, Wanlin M, Orcau Å, Rodes A, Dedicoat M, Antoun F, van Deutekom H, Keizer S, Abubakar I.Tuberculosis control in big cities and urban risk groups in the European Union: a consensus statement. Euro Surveill. 2014 Mar 6;19(9). pii: 20728.
12. Tankimovich M. Barriers to and interventions for improved tuberculosis detection and treatment among homeless and immigrant populations: a literature review. J Community Health Nurs. 2013;30(2):83-95. http://dx.doi.org/10.1080/07370016.2013.778723
13. Fenner L, Gagneux S, Janssens JP, Fehr J, Cavassini M, Hoffmann M, Bernasconi E, Schrenzel J, Bodmer T, Böttger EC, Helbling P, Egger M; Swiss HIV Cohort and Molecular Epidemiology of Tuberculosis Study Groups.Tuberculosis in HIV-negative and HIV-infected patients in a low-incidence country: clinical characteristics and treatment outcomes. PLoS One. 2012;7(3):e34186. Epub 2012 Mar 30. http://dx.doi.org/10.1371/journal.pone.0034186
14. World Health Organization (WHO). WHO policy on TB/HIV collaborative activities: guidelines for national programmes and other stakeholders. Geneva, 2012. Available at: http://whqlibdoc.who.int/publications/2012/9789241503006_eng.pdf?ua=1.
15. Joint United Nations Programme on HIV/AIDS (UNAIDS). Getting to zero: 2011-2015 Strategy. Geneva, 2010. Available at: http://www.unaids.org/en/media/unaids/contentassets/documents/unaidspublication/2010/JC2034_UNAIDS_Strategy_en.pdf.
16. World Health Organization (WHO). Consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection. Geneva, 2013. Available at: http://www.who.int/iris/bitstream/10665/85321/1/9789241505727_eng.pdf?ua=1.
17. World Health Organization (WHO). Tuberculosis in prison. http://www.who.int/tb/challenges/prisons/en/
18. Telisinghe L, Fielding KL, Malden JL, Hanifa Y, Churchyard GJ, Grant AD, Charalambous S. High tuberculosis prevalence in a South African prison: the need for routine tuberculosis screening. PLoS One. 2014 Jan 30;9(1):e87262. doi: 10.1371/journal.pone.0087262. http://dx.doi.org/10.1371/journal.pone.0087262
19. Winetsky DE, Almukhamedov O, Pulatov D, Vezhnina N, Dooronbekova A, Zhussupov B.Prevalence, risk factors and social context of active pulmonary tuberculosis among prison inmates in Tajikistan. PLoS One. 2014 Jan 20;9(1):e86046. http://dx.doi.org/10.1371/journal.pone.0086046
20. Fazel S, Baillargeon J. The health of prisoners. Lancet. 2011 Mar 12;377(9769):956-65. Epub 2010 Nov 18. http://dx.doi.org/10.1016/S0140-6736(10)61053-7
21. Baussano I, Williams BG, Nunn P, Beggiato M, Fedeli U, Scano F. Tuberculosis incidence in prisons: a systematic review. PLoS Med. 2010 Dec 21;7(12):e1000381. http://dx.doi.org/10.1371/journal.pmed.1000381
22. Zenner D, Southern J, van Hest R, DeVries G, Stagg HR, Antoine D, Abubakar I. Active case finding for tuberculosis among high-risk groups in low-incidence countries. Int J Tuberc Lung Dis. 2013 May;17(5):573-82. http://dx.doi.org/10.5588/ijtld.12.0920
23. Dara M, Chadha SS, Vinkeles Melchers NV, van den Hombergh J, Gurbanova E, Al-Darraji H, van der Meer JB; International Union Against Tuberculosis and Lung Disease.Time to act to prevent and control tuberculosis among inmates. Int J Tuberc Lung Dis. 2013 Jan;17(1):4-5. http://dx.doi.org/10.5588/ijtld.12.0909
24. International Organization for Migration (IOM). World Migration Report 2013: Migrant Well-being and Development. Geneva, 2013.
25. Sandgren A, Schepisi MS, Sotgiu G, Huitric E, Migliori GB, Manissero D, van der Werf MJ, Girardi E.Tuberculosis transmission between foreign- and native-born populations in the EU/EEA: a systematic review. Eur Respir J. 2014 Apr43(4):1159-71. Epub 2013 Oct 10. http://dx.doi.org/10.1183/09031936.00117213
26. Kamper-Jørgensen Z, Andersen AB, Kok-Jensen A, Kamper-Jørgensen M, Bygbjerg IC, Andersen PH, Thomsen VO, Lillebaek T. Migrant tuberculosis: the extent of transmission in a low burden country. BMC Infect Dis. 2012 Mar 18;12:60. http://dx.doi.org/10.1186/1471-2334-12-60
27. Franzetti F, Codecasa L, Matteelli A, Degli Esposti A, Bandera A, Lacchini C, Lombardi A, Pinsi G, Zanini F, El-Hamad I, Gori A. Genotyping analyses of tuberculosis transmission among immigrant residents in Italy. Clin Microbiol Infect. 2010 Aug;16(8):1149-54. Epub 2009 Oct 14. http://dx.doi.org/10.1111/j.1469-0691.2009.03080.x
28. Zammarchi L, Bartalesi F, Bartoloni A. Tuberculosis in tropical areas and immigrants. Mediterr J Hematol Infect Dis. 2014 Jun 1;6(1):e2014043. http://dx.doi.org/10.4084/mjhid.2014.043
29. McCarthy AE, Weld LH, Barnett ED, So H, Coyle C, Greenaway C, Stauffer W, Leder K, Lopez-Velez R, Gautret P, Castelli F, Jenks N, Walker PF, Loutan L, Cetron M; GeoSentinel Surveillance Network. Spectrum of illness in international migrants seen at GeoSentinel clinics in 1997-2009, part 2: migrants resettled internationally and evaluated for specific health concerns. Clin Infect Dis. 2013 Apr56(7):925-33. Epub 2012 Dec 7. http://dx.doi.org/10.1093/cid/cis1016
30. McPherson ME, Kelly H, Patel MS, Leslie D. Persistent risk of tuberculosis in migrants a decade after arrival in Australia. Med J Aust. 2008 May 5;188(9):528-31. PMid:18459925
31. Zignol M, Hosseini MS, Wright A, et al. Global incidence of multidrug-resistant tuberculosis. J Infect Dis 2006; 194(4):479-85. http://dx.doi.org/10.1086/505877 PMid:16845631
32. World Health Organization (WHO). Policy update: Xpert MTB/RIF assay for the diagnosis of pulmonary and extrapulmonary TB in adults and children (WHO/HTM/TB/2013.16). Geneva, 2013. Available at: http://www.who.int/iris/bitstream/10665/112472/1/9789241506335_eng.pdf?ua=1.
33. Falzon D, Jaramillo E, Schünemann HJ, et al. WHO guidelines for the programmatic management of drug-resistant tuberculosis: 2011 update. Eur Respir J 2011; 38: 516-28. http://dx.doi.org/10.1183/09031936.00073611 PMid:21828024
34. Van Deun A et al. Short, highly effective, and inexpensive standardized treatment of multidrug-resistant tuberculosis. American Journal of Respiratory and Critical Care Medicine, 2010, 182(5): 684-692. http://dx.doi.org/10.1164/rccm.201001-0077OC PMid:20442432
35. Zumla A, Mwaba P, Huggett J, et al. Reflections on the white plague. Lancet Infect Dis 2009; 9(3): 197-202. http://dx.doi.org/10.1016/S1473-3099(09)70045-3
36. World Health Organization (WHO). TB: a global emergency, WHO report on the TB epidemic. WHO/TB/94.177. Geneva, 1994. Available at: http://www.who.int/iris/handle/10665/58749.
37. International Union Against Tuberculosis and Lung Disease (IUATLD). Tuberculosis Guide for Low Income Countries, 4th ed. IUATLD, Paris, 1996.
38. World Health Organization (WHO). WHO tuberculosis programme: framework for effective tuberculosis control. WHO/TB/94.179. Geneva, 1994. Available at: http://whqlibdoc.who.int/hq/1994/WHO_TB_94.179.pdf?ua=1.
39. Dye C. Evolution of Tuberculosis Control and Prospects for Reducing Tuberculosis Incidence, Prevalence, and Deaths Globally (Reprinted) JAMA, June 8, 2005-Vol 293, No. 22
40. World Health Organization (WHO)/Stop-TB Partnership. The Global Plan to Stop TB: Phase 1: 2001-2005. WHO/CDS/STB/2001.16. WHO, Geneva, 2001. Available at: http://www.stoptb.org/assets/documents/global/plan/GLOBAL_PLAN_TO_STOP_TB_2001_2005.pdf
41. The Global Fund to Fight AIDS, Tuberculosis and Malaria (GFATM). Funding and spending. http://www.theglobalfund.org/en/about/fundingspending/
42. Raviglione MC, Uplekar MW. WHO's new Stop TB Strategy. Lancet 2006; 367: 952-5. http://dx.doi.org/10.1016/S0140-6736(06)68392-X
43. World Health Organization (WHO). The Stop TB Strategy. WHO/HTM/TB/2006.368, Geneva, 2006. Available at: http://whqlibdoc.who.int/hq/2006/WHO_HTM_STB_2006.368_eng.pdf?ua=1
44. Raviglione MC, Uplekar MW.WHO's new Stop TB Strategy. Lancet. 2006 Mar 18;367(9514):952-5. http://dx.doi.org/10.1016/S0140-6736(06)68392-X
45. Onozaki I., Raviglione MC. Stopping tuberculosis in the 21st century: Goals and strategies. Respirology (2010) 15, 32-43. http://dx.doi.org/10.1111/j.1440-1843.2009.01673.x PMid:20199633
46. World Health Organization (WHO)/Stop-TB Partnership. The Global Plan to Stop TB 2006-2015: Actions for Life towards a World Free of tuberculosis. WHO/HTM/STB/2006.35, Geneva, 2006. Available at: http://www.stoptb.org/assets/documents/global/plan/GlobalPlanFinal.pdf
47. World Health Organization (WHO). Global strategy and targets for tuberculosis prevention, care and control beyond 2015. Geneva, 2013. Available at: http://www.who.int/tb/post2015_TBstrategy.pdf?ua=1
48. McNerney R, Maeurer M, Abubakar I, et al. Tuberculosis diagnostics and biomarkers: needs, challenges, recent advances and opportunities. J Infect Dis 2012; 205 (suppl 2): S147-58. http://dx.doi.org/10.1093/infdis/jir860 PMid:22496353
49. World Health Organization (WHO). The Use of Bedaquiline in the Treatment of Multidrug-Resistant Tuberculosis: Interim Policy Guidance. WHO/HTM/TB/2013.6. Geneva; 2013. Available at: http://www.who.int/iris/bitstream/10665/84879/1/9789241505482_eng.pdf?ua=1
50. Ryan NJ, Lo JH. Delamanid: first global approval. Drugs. 2014 Jun;74(9):1041-5. doi: 10.1007/s40265-014-0241-5. http://dx.doi.org/10.1007/s40265-014-0241-5